GH Research PLC SEC filings GHRS
GH Research PLC has 199 filings in SEC EDGAR's recent list, going back to Apr 20, 2021. Its latest annual report, Form 20-F, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 9, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 19, 2026 | — |
| CORRESP | Letter to the SEC | May 15, 2026 | — |
| UPLOAD | Letter from the SEC | May 15, 2026 | — |
| EFFECT | Filing | Mar 7, 2025 | — |
| CORRESP | Letter to the SEC | Mar 5, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 3, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2023 | — |
| CORRESP | Letter to the SEC | Jun 2, 2023 | — |
| UPLOAD | Letter from the SEC | May 25, 2023 | — |
| EFFECT | Filing | Mar 17, 2023 | — |
| CORRESP | Letter to the SEC | Mar 14, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 14, 2023 | — |
| EFFECT | Filing | Jun 24, 2021 | — |
| CERT | Filing | Jun 23, 2021 | — |
| 8-A12B | Filing | Jun 22, 2021 | — |
| CORRESP | Letter to the SEC | Jun 22, 2021 | — |
| CORRESP | Letter to the SEC | Jun 22, 2021 | — |
| CORRESP | Letter to the SEC | Jun 21, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2021 | — |
| CORRESP | Letter to the SEC | Jun 4, 2021 | — |
| UPLOAD | Letter from the SEC | May 18, 2021 | — |
| DRS | Filing | Apr 20, 2021 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GHRS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Ireland
- Headquarters
- Dublin 2, Ireland
- SEC filer status
- Accelerated filer, Emerging growth company
- SEC CIK
- 1855129
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.